Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous iron oxide contrast for cardiac MRI
2014-002455-26Phase 4Active
- Sponsor
- Karolinska Institutet
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of ferric carboxymaltose in myocardial infarction (MI), myocarditis, cardiac fibrosis and 3 more, sponsored by Karolinska Institutet. Primary endpoint: Myocardial extracellular volume and partition coefficient. Started Jul 2014; status: active.
02
Drugs
ferric carboxymaltose
03
Conditions
myocardial infarction (MI)myocarditiscardiac fibrosisamyloid cardiomyopathycoronary arteriosclerosis
Beyond the preview
Go deeper on 2014-002455-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002455-26.